Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
5(42%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
8%
Ph not_applicable
6
50%
Ph early_phase_1
1
8%

Phase Distribution

1

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
N/ANon-phased studies
6(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

12

all time

Status Distribution
Active(6)
Completed(5)
Other(1)

Detailed Status

Completed5
Recruiting3
Active, not recruiting2
unknown1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
5
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (12.5%)
Phase 21 (12.5%)
N/A6 (75.0%)

Trials by Status

completed542%
recruiting325%
unknown18%
active_not_recruiting217%
not_yet_recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
12